Protection against Herpetic Ocular Disease by Immunotherapy with Monoclonal Antibodies to Herpes simplex Virus Glycoproteins

Intervirology ◽  
1988 ◽  
Vol 29 (1) ◽  
pp. 39-49 ◽  
Author(s):  
Joseph F. Metcalf ◽  
Subhendra Chatterjee ◽  
Junichi Koga ◽  
Richard J. Whitley
1992 ◽  
Vol 2 (4) ◽  
pp. 175-178 ◽  
Author(s):  
P. Bordin ◽  
U. Merlin ◽  
P. Pugina ◽  
G. Benzi ◽  
R. Sichirollo

Herpetic ocular disease never produces well-identifiable morphological aspects. It is expensive, complicated and slow to culture Herpes simplex virus. The validity of the fluorescent monoclonal antibodies test was investigated using corneal cells with or without a sure herpetic lesion. The tests, on 36 cases without sure herpetic lesions, were always negative, while of the 42 patients with a clinically ascertained herpetic lesion, 38 were positive (90.5%) and 4 negative (9.5%), two of these on account of inadeguate tissue preparations. Thus, this method can prove useful and reliable for diagnostic purposes.


1999 ◽  
Vol 37 (8) ◽  
pp. 2717-2718 ◽  
Author(s):  
Jan-Åke Liljeqvist ◽  
Bo Svennerholm ◽  
Tomas Bergström

The purpose of this study was to evaluate the performance of a herpes simplex virus (HSV) type 1-specific anti-glycoprotein C-1 monoclonal antibody (MAb) and a type 2-specific anti-glycoprotein G-2 MAb for typing of 2,400 clinical HSV-1 isolates and 2,400 clinical HSV-2 isolates, respectively, using an enzyme immunoassay. The anti-HSV-1 MAb showed sensitivity and specificity of 100%, and the anti-HSV-2 MAb showed a sensitivity of 99.46% and 100% specificity, indicating that these MAbs are suitable for typing of clinical HSV isolates.


Sign in / Sign up

Export Citation Format

Share Document